A detailed history of Bank Of America Corp transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Bank Of America Corp holds 867,059 shares of TAK stock, worth $12 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
867,059
Previous 1,484,009 41.57%
Holding current value
$12 Million
Previous $20.6 Million 45.57%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$12.6 - $13.67 $7.77 Million - $8.43 Million
-616,950 Reduced 41.57%
867,059 $11.2 Million
Q1 2024

May 15, 2024

BUY
$13.89 - $15.04 $9.02 Million - $9.77 Million
649,696 Added 77.87%
1,484,009 $20.6 Million
Q4 2023

Feb 14, 2024

SELL
$13.36 - $15.43 $148,456 - $171,458
-11,112 Reduced 1.31%
834,313 $11.9 Million
Q2 2023

Aug 14, 2023

SELL
$15.57 - $17.11 $7.03 Million - $7.72 Million
-451,412 Reduced 34.81%
845,425 $13.3 Million
Q1 2023

May 12, 2023

BUY
$15.28 - $16.48 $6.72 Million - $7.25 Million
440,000 Added 51.35%
1,296,837 $21.4 Million
Q4 2022

Feb 10, 2023

SELL
$12.42 - $15.62 $3.14 Million - $3.94 Million
-252,419 Reduced 22.76%
856,837 $13.4 Million
Q3 2022

Nov 14, 2022

BUY
$12.8 - $28.65 $3.36 Million - $7.52 Million
262,641 Added 31.02%
1,109,256 $14.4 Million
Q2 2022

Aug 12, 2022

SELL
$13.12 - $15.03 $33.3 Million - $38.2 Million
-2,541,293 Reduced 75.01%
846,615 $11.9 Million
Q1 2022

May 16, 2022

BUY
$13.54 - $15.35 $3.13 Million - $3.55 Million
231,268 Added 7.33%
3,387,908 $48.5 Million
Q4 2021

Feb 08, 2022

SELL
$13.17 - $16.4 $12 Million - $14.9 Million
-910,856 Reduced 22.39%
3,156,640 $43 Million
Q3 2021

Nov 15, 2021

BUY
$16.3 - $17.26 $31.2 Million - $33.1 Million
1,916,142 Added 89.07%
4,067,496 $66.6 Million
Q2 2021

Sep 13, 2021

BUY
$16.55 - $18.64 $35.6 Million - $40.1 Million
2,151,354 New
2,151,354 $36.2 Million

Others Institutions Holding TAK

About TAKEDA PHARMACEUTICAL CO LTD


  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $43.1B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.